Norway· NO-ID_16AD742E-9D68-414C-9A67-F00E2F7B440D
Ovitrelle
A choriogonadotropin alfa product containing choriogonadotropin alfa, registered in Norway by Merck. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Choriogonadotropin alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC G03GA08 (choriogonadotropin alfa), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Choriogonadotropin alfa · ATC G03GA08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Choriogonadotropin Alfa
- Manufacturer
- Merck
- Country
- Norway (NO)
- ATC code
- G03GA08
- ATC class
- Choriogonadotropin alfa
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_16AD742E-9D68-414C-9A67-F00E2F7B440D
- no_varenummer3547100.5
- gtin4065267318202
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Choriogonadotropin alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenOvitrelle 250 mikrogram/0,5 ml Injektionsvätska, lösning i förfylld injektionspennaMerck Europe B.V.
- SwitzerlandOvitrelle 250 µg, Injektionslösung in einer FertigspritzeMerck (Schweiz) AG
- CzechiaOVITRELLEMerck Europe B.V., Amsterdam
- IrelandOvitrelle 250 micrograms/0.5 mL solution for injection in pre-filled syringeAres-Serono (Europe) Limited
- PolandOvitrelleMerck Europe B.V.
- FinlandOvitrelleMerck Europe B.V.
- United KingdomOvitrelle 250microgram powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandOvitrelleMerck Europe B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ovitrelle
- Liechtenstein · Ovitrelle
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8cebd374-15ad-49f7-bb21-e51e75df568b GET /v1/drugs/8cebd374-15ad-49f7-bb21-e51e75df568b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Koriongonadotropin alfa",
"merkevare_id": "ID_16AD742E-9D68-414C-9A67-F00E2F7B440D",
"name_form_strength": "Ovitrelle inj, oppl 250 mikrog/0,5 ml",
"prescription_group": "C"
}See everything about choriogonadotropin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.